UTHSC Article: Streptococcus Vaccine Developed by UTHSC Professor of Medicine James B. Dale to Begin Clinical Trial The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization and Research (CECR) located at the University of Saskatchewan, and Vaxent in Memphis, Tennessee, are pleased to announce the initiation of a Phase 1 clinical (read more)
UTHSC
UTRF Tech Talks: Ask An Entrepreneur
September 10, 2015 UTHSC Hamilton Eye Institute, Freeman Auditorium 12:00 PM – 1:00 PM (lunch is provided) RSVP to Tinieka Thrailkill | 901- 448-7827 Since 2012, UTHSC faculty have launched 10 new life science startup companies. At this workshop, you will hear directly from UTHSC faculty entrepreneurs about the challenges and successes they’ve had launching (read more)
GTx and UTRF Enter Into Exclusive License Agreement
GTx And UTRF Enter Into Exclusive License Agreement To Develop SARD Drug Candidate To Treat Castration-Resistant Prostate Cancer